Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
A new study finds that carotid near-occlusion (NO) doesn't significantly raise the risk of stroke or death within 30 days of carotid endarterectomy (CEA) compared to conventional stenosis — but it does more than double the odds of hyperperfusion syndrome post-surgery. Nearly a third of CEA patients had carotid NO, with most cases being the subtle variety. Tight blood pressure control after the procedure is key to preventing serious complications.
A prospective cohort study out of Helsinki University Hospital found that carotid near-occlusion (NO) — present in nearly one-third of patients scheduled for carotid endarterectomy (CEA) — doesn't significantly increase the risk of preoperative recurrent stroke or 30-day procedural stroke and death compared to conventional carotid stenosis. That's reassuring for surgeons, but there's an important caveat: hyperperfusion syndrome was more than twice as common in patients with NO after the procedure.
The study followed 443 patients (mean age 70; 68% men) treated between 2012 and 2015. Of those with NO, 87% had the subtle form and 13% had full collapse. One patient with subtle NO died from an intracranial hemorrhage linked to hyperperfusion syndrome, underscoring the real stakes of this complication.
By the Numbers:
Why it matters: While carotid NO doesn't appear to make CEA dramatically riskier overall, the elevated hyperperfusion risk means clinicians need to be especially vigilant with perioperative blood pressure management in these patients to prevent potentially fatal intracranial hemorrhage.
